Routinely measuring symptom burden and health-related quality of life in dialysis patients: first results from the Dutch registry of patient-reported outcome measures
Esmee M. van der Willik(Leiden University Medical Center), Yvette Meuleman(Leiden University Medical Center), Marc H. Hemmelder(Nefrovisie), Willem Jan W. Bos(St. Antonius Ziekenhuis), Frans J. van Ittersum(Vrije Universiteit Amsterdam), Judith M. Hoogendijk-van den Akker(Isala), Friedo W. Dekker(Leiden University Medical Center), Hans A. J. Bart(Nierstichting)
Cited by 104
Related Papers
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877
External validation of prognostic models: what, why, how, when and where?
|Clinical Kidney Journal|2020|808
When do we need competing risks methods for survival analysis in nephrology?
|Nephrology Dialysis Transplantation|2013|674
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe
|Kidney International|2020|502
Confounding: What it is and how to deal with it
|Kidney International|2007|480